课题基金 / 基金详情

项目摘要

项目成果

Brian Akerley的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Streptococcus pneumoniae is one of the top bacterial causes of keratitis worldwide and can lead to significant vision loss. The mainstay of therapy continues to be antibiotics; however, bacteria are not always susceptible, and antibiotics are unable to reduce the host- and bacterium-mediated damage associated with S. pneumoniae keratitis. Our findings strongly indicate that the outer polysaccharide capsule of S. pneumoniae, considered a major virulence factor of this organism, impedes attachment of the bacteria to the corneal surface. Preliminary data show that the bacteria produce markedly less capsule when adhered to corneal epithelial cells, which suggest that they regulate capsule to adapt to the corneal niche. Therefore, our central hypothesis is that S. pneumoniae adapts to down-regulate capsule in the present of corneal cells so that attachment and persistence are increased. We will test our hypothesis by comparing capsule quantities of bacteria that are adherent to corneal cells and the corneal surface to bacteria that are not adherent. We will then determine the genes that are necessary for corneal attachment and colonization by a prioritized genetic screen of a library of mutants in vitro and in vivo, followed by validation with functional analyses with targeted mutations. The long- term goals of this study are to identify and characterize the factors that repress bacterial capsule in the cornea and promote attachment to cause keratitis. Understanding the processes of regulation and colonization will aid in driving development of novel therapies to preserve the cornea.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury
  • 批准号:
    10700810
  • 项目类别:
  • 资助金额:
    $28.62万
  • 财政年份:
    2022
  • 负责人:
    Brian Akerley
  • 依托单位:
Targeted delivery of novel miRNA-based therapeutics for pneumonia-induced acute lung injury
  • 批准号:
    10395376
  • 项目类别:
  • 资助金额:
    $29.69万
  • 财政年份:
    2022
  • 负责人:
    Brian Akerley
  • 依托单位:
HEMOGLOBIN-INDUCED VIRULENCE IN STREPTOCOCCUSPNEUMONIAE
Mechanisms of Haemophilus influenzae pathogenesis in the lung
海外基金